Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bullous skin diseases

References

• Riemekasten G, Hahn BH. Key autoantigens in SLE. Rheumatology (Oxford) 2005; 44(8)975–982
   PubMed Web of Science ®Google Scholar
• Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12: 991–1045
   PubMed Web of Science ®Google Scholar
• Reines BP. Hypothesis. Bystanders or bad seeds? Many autoimmune-target cells may be transforming to cancer and signalling “danger” to the immune system. Autoimmunity 2001; 33(2)121–134
   PubMed Web of Science ®Google Scholar
• Diamond B, et al. The role of somatic mutation in the pathogenic anti-DNA response. Annu Rev Immunol 1992; 10: 731–757
   PubMed Web of Science ®Google Scholar
• Sciascia SA, et al. Immunization of nonautoimmune mice with DNA binding domains of the largest subunit of RNA polymerase I results in production of anti-dsDNA and anti-Sm/RNP antibodies. Autoimmunity 2007; 40(1)38–47
   PubMed Web of Science ®Google Scholar
• Goding J. Advocatus diaboli: What is not known about autoimmune disease. The autoimmune diseases, NR Rose, IR Mackay. Elsevier, Amsterdam/Tokyo 2006; 1085–1093
   Google Scholar
• Chiovato L, et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 2003; 139(5 Pt 1)346–351
   PubMed Web of Science ®Google Scholar
• Feltkamp T. The mystery of autoimmune diseases. The decade pf autoimmunity, Y Shoenfeld. Elsevier, Amsterdam/Tokyo 1999; 1–5
   Google Scholar
• Liu K, Mohan C. What do mouse models teach us about human SLE?. Clin Immunol 2006; 119(2)123–130
   PubMed Web of Science ®Google Scholar
• Sherer Y, et al. Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004; 34(2)501–537
   PubMed Web of Science ®Google Scholar
• Sherer Y, Shoenfeld Y. Autoantibody explosion in lupus: 155 autoantibodies in SLE. Lupus 2007; 16(Abstr Suppl)42
   Google Scholar
• Heissmeyer V, Ansel KM, Rao A. A plague of autoantibodies. Nat Immunol 2005; 6(7)642–644
   PubMed Web of Science ®Google Scholar
• Block SR. A brief history of twins. Lupus 2006; 15(2)61–64
   PubMed Web of Science ®Google Scholar
• Cantor RM, et al. Systemic lupus erythematosus genome scan: Support for linkage at 1q23, 2q33, 16q12-13, and 17q21-23 and novel evidence at 3p24, 10q23-24, 13q32, and 18q22-23. Arthritis Rheum 2004; 50(10)3203–3210
   PubMed Web of Science ®Google Scholar
• Lipsky PE. Systemic lupus erythematosus: An autoimmune disease of B cell hyperactivity. Nat Immunol 2001; 2(9)764–766
   PubMed Web of Science ®Google Scholar
• Liossis S-N, Tsokos G. B-cells in human systemic lupus erythematosus. Systemic lupus erythematosus, GC Tsokos, C Gordon, JS Smolen. Mosby/Elsevier, St. Louis, MO/Amsterdam 2007; 103–108
   Google Scholar
• Shim YK, et al. B cells behaving badly. Br J Haematol 2007; 139(5)658–662
   PubMed Web of Science ®Google Scholar
• Remmers EF, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007; 357(10)977–986
   PubMed Web of Science ®Google Scholar
• Cervino AC, Tsinoremas NF, Hoffman RW. A genome-wide study of lupus: Preliminary analysis and data release. Ann N Y Acad Sci 2007; 1110: 131–139
   PubMed Web of Science ®Google Scholar
• Ikehara S. Treatment of autoimmune diseases by hematopoietic stem cell transplantation. Exp Hematol 2001; 29(6)661–669
   PubMed Web of Science ®Google Scholar
• van Bekkum DW. Stem cell transplantation for autoimmune disorders. Preclinical experiments. Best Pract Res Clin Haematol 2004; 17(2)201–222
   PubMed Web of Science ®Google Scholar
• Ikehara S. Stem cell transplantation for autoimmune diseases: What can we learn from experimental models?. Autoimmunity 2008, (in press)
   PubMed Web of Science ®Google Scholar
• Smith-Berdan S, et al. Reversal of autoimmune disease in lupus-prone New Zealand black/New Zealand white mice by nonmyeloablative transplantation of purified allogeneic hematopoietic stem cells. Blood 2007; 110(4)1370–1378
   PubMed Web of Science ®Google Scholar
• Marmont AM. Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications. Best Pract Res Clin Haematol 2004; 17(2)223–232
   PubMed Web of Science ®Google Scholar
• Sykes M, Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature 2005; 435(7042)620–627
   PubMed Web of Science ®Google Scholar
• Marmont AM. Immune ablation with stem-cell rescue: A possible cure for systemic lupus erythematosus?. Lupus 1993; 2(3)151–156
   PubMed Web of Science ®Google Scholar
• Tyndall A, LeBlanc K. Stem cells and rheumatology: Update on adult stem cell therapy in autoimmune diseases. Arthritis Rheum 2006; 55(4)521–525
   PubMed Web of Science ®Google Scholar
• Tyndall A, Saccardi R. Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: Results from phase I/II studies, prospective randomized trials and future directions. Clin Exp Immunol 2005; 141(1)1–9
   PubMed Web of Science ®Google Scholar
• Burt RK, et al. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: Getting closer to a cure?. Blood 2002; 99(3)768–784
   PubMed Web of Science ®Google Scholar
• Muraro PA, Douek DC. Renewing the T cell repertoire to arrest autoimmune aggression. Trends Immunol 2006; 27(2)61–67
   PubMed Web of Science ®Google Scholar
• de Kleer I, et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood 2006; 107(4)1696–1702
   PubMed Web of Science ®Google Scholar
• Hughes G. Hughes syndrome: The growth of antiphospholipid syndrome. Lupus 2007; 16(Suppl)4–5
   Google Scholar
• Woolf SH, George JN. Evidence-based medicine. Interpreting studies and setting policy. Hematol Oncol Clin North Am 2000; 14(4)761–784
   PubMed Web of Science ®Google Scholar
• Marmont AM, et al. Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus 1997; 6(6)545–548
   PubMed Web of Science ®Google Scholar
• Marmont AM, et al. Long term complete remission of severe nephrotic syndrome secondary to diffuse global (IV-G) lupus nephritis following autologous, haematopoietic peripheral stem (CD34+) cell transplantation. Lupus 2006; 15(1)44–46
   PubMed Web of Science ®Google Scholar
• Burt RK, Traynor A, Ramsey-Goldman R. Hematopoietic stem-cell transplantation for systemic lupus erythematosus. N Engl J Med 1997; 337(24)1777–1778
   PubMed Web of Science ®Google Scholar
• Musso M, et al. Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome. Lupus 1998; 7(7)492–494
   PubMed Web of Science ®Google Scholar
• Fouillard L, et al. Control of severe systemic lupus erythematosus after high-dose immunusuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood. Lupus 1999; 8(4)320–323
   PubMed Web of Science ®Google Scholar
• Trysberg E, Lindgren I, Tarkowski A. Autologous stem cell transplantation in a case of treatment resistant central nervous system lupus. Ann Rheum Dis 2000; 59(3)236–238
   PubMed Web of Science ®Google Scholar
• Rosen O, et al. Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells. Arthritis Res 2000; 2(4)327–336
   PubMedGoogle Scholar
• Lehnhardt FG, et al. Autologous blood stem cell transplantation in refractory systemic lupus erythematodes with recurrent longitudinal myelitis and cerebral infarction. Lupus 2006; 15(4)240–243
   PubMed Web of Science ®Google Scholar
• Brunner M, et al. Autologous blood stem cell transplantation in refractory systemic lupus erythematosus with severe pulmonary impairment: A case report. Arthritis Rheum 2002; 46(6)1580–1584
   PubMed Web of Science ®Google Scholar
• Talaulikar D, et al. Autologous peripheral blood stem cell transplantation with in vivo T-cell depletion for life threatening refractory systemic lupus erythematosus. Lupus 2005; 14(2)159–163
   PubMedGoogle Scholar
• Elhasid R, et al. Disappearance of diffuse calcinosis following autologous stem cell transplantation in a child with autoimmune disease. Bone Marrow Transplant 2004; 33(12)1257–1259
   PubMed Web of Science ®Google Scholar
• Jayne D, et al. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 2004; 13(3)168–176
   PubMed Web of Science ®Google Scholar
• Burt RK, et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 2006; 295(5)527–535
   PubMed Web of Science ®Google Scholar
• Gharib MI, Burnett AK. Chemotherapy-induced cardiotoxicity: Current practice and prospects of prophylaxis. Eur J Heart Fail 2002; 4(3)235–242
   PubMed Web of Science ®Google Scholar
• Saccardi R, et al. Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis. Bone Marrow Transplant 2004; 34(10)877–881
   PubMedGoogle Scholar
• Loh Y, et al. Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus patients with cardiac dysfunction: Feasibility and reversibility of ventricular and valvular dysfunction with transplant-induced remission. Bone Marrow Transplant 2007; 40(1)47–53
   PubMed Web of Science ®Google Scholar
• Traynor AE, et al. Prevalence and reversibility of pulmonary dysfunction in refractory systemic lupus: Improvement correlates with disease remission following hematopoietic stem cell transplantation. Chest 2005; 127(5)1680–1689
   PubMed Web of Science ®Google Scholar
• Ouyang J, et al. [A pilot study in treatment of systemic lupus erythematosus by autologous bone marrow transplant]. Zhonghua Nei Ke Za Zhi 2001; 40(4)229–231
   PubMedGoogle Scholar
• Zhao X, Fu Y, Peng X. Autologous hematopoietic stem cell transplantation in the treatment of systemic lupus erythematosus. Bone Marrow Transplant 2002; 29(Suppl 1)5
   Google Scholar
• Lisukov IA, et al. High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus. Lupus 2004; 13(2)89–94
   PubMed Web of Science ®Google Scholar
• Kim J, Hong S, Yoon Sea. Autologous stem cell transplantation using G-CSF primed bone marrow in severe refractory systemic lupus erythematosus. Bone Marrow Transplant 2005; 35(Suppl 2)232
   Google Scholar
• Gualandi F, et al. Autologous stem cell transplantation for severe autoimmune diseases: A 10-year experience. Ann N Y Acad Sci 2007; 1110: 455–464
   PubMed Web of Science ®Google Scholar
• Gladman DD, et al. Clinically active serologically quiescent systemic lupus erythematosus. J Rheumatol 2003; 30(9)1960–1962
   PubMed Web of Science ®Google Scholar
• Alexander T, Massenkeil G, Mei Hea. Normalisation of peripheral B cell abnormalities after immunoablation and autologous stem cell transplantation in refractory human lupus erythematosus. Lupus 2007; 16(Abstr Suppl)99–100
   Google Scholar
• Hoyer BF, et al. Long-lived plasma cells and their contribution to autoimmunity. Ann N Y Acad Sci 2005; 1050: 124–133
   PubMed Web of Science ®Google Scholar
• Wilson WA, Gharavi AE, Piette JC. International classification criteria for antiphospholipid syndrome: Synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium. Lupus 2001; 10(7)457–460
   PubMedGoogle Scholar
• Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346(10)752–763
   PubMed Web of Science ®Google Scholar
• Roubey R. Antiphospholipid syndrome. The autoimmune diseases, NR Rose, IR Mackay. Elsevier, Amsterdam/Tokyo 2006; 381–399
   Google Scholar
• Khamastha M. Hughes syndrome: Antiphospholipid syndrome. Springer Semin Immunopathol, London 2006
   Google Scholar
• Asherson RA, et al. Catastrophic antiphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines. Lupus 2003; 12(7)530–534
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y. Systemic antiphospholipid syndrome. Lupus 2003; 12(7)497–498
   PubMed Web of Science ®Google Scholar
• Hughes G. Hughes syndrome: The growth of antiphospholipid syndrome. Lupus 2007; 16: 4–5
   Google Scholar
• Adachi Y, et al. Effect of bone marrow transplantation on antiphospholipid antibody syndrome in murine lupus mice. Immunobiology 1995; 192(3/4)218–230
   PubMed Web of Science ®Google Scholar
• Hashimoto N, et al. Autologous hematopoietic stem cell transplantation for refractory antiphospholipid syndrome causing myocardial necrosis. Bone Marrow Transplant 2004; 33(8)863–866
   PubMed Web of Science ®Google Scholar
• Statkute L, et al. Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation. Blood 2005; 106(8)2700–2709
   PubMed Web of Science ®Google Scholar
• Gur-Lavi M. Long-term remission with allogenic bone marrow transplantation in systemic lupus erythematosus. Arthritis Rheum 1999; 42(8)1777
   PubMed Web of Science ®Google Scholar
• Khorshid O, et al. Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus. J Rheumatol 2004; 31(12)2513–2516
   PubMed Web of Science ®Google Scholar
• Burt RK, et al. Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism. Arthritis Rheum 2004; 50(8)2466–2470
   PubMed Web of Science ®Google Scholar
• Pavletic SZ. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for autoimmune disease. Arthritis Rheum 2004; 50(8)2387–2390
   PubMed Web of Science ®Google Scholar
• Olalla JI, et al. Disappearance of lupus anticoagulant after allogeneic bone marrow transplantation. Bone Marrow Transplant 1999; 23(1)83–85
   PubMed Web of Science ®Google Scholar
• Vanikar AV, et al. Hematopoietic stem cell transplantation in autoimmune diseases: The Ahmedabad experience. Transplant Proc 2007; 39(3)703–708
   PubMed Web of Science ®Google Scholar
• Li N, Liu Z, Hilario-Vargas J, Diaz LA. Bullous skin diseases: Pemphigus and pemphigoid. The autoimmune diseases, NR Rose, IR Mackay. Elsevier, Amsterdam/Tokyo 2006; 789–806
   Google Scholar
• Szabolcs P, et al. Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease. Bone Marrow Transplant 2002; 30(5)327–329
   PubMed Web of Science ®Google Scholar
• Herr AL, et al. Successful anti-CD20 antibody treatment of pemphigus foliaceus after unrelated cord blood transplantation. Bone Marrow Transplant 2005; 35(4)427–428
   PubMed Web of Science ®Google Scholar
• Oyama Y, et al. High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory pemphigus foliaceus. Bone Marrow Transplant 2004; 34(12)1097–1098
   PubMed Web of Science ®Google Scholar
• Brenner MK. Haematopoietic stem cell transplantation for autoimmune disease: Limits and future potential. Best Pract Res Clin Haematol 2004; 17(2)359–374
   PubMed Web of Science ®Google Scholar
• Burt RK, et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: The evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum 2006; 54(12)3750–3760
   PubMed Web of Science ®Google Scholar
• Loh Y, et al. Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: Role of conditioning regimen used. Blood 2007; 109(6)2643–2648
   PubMed Web of Science ®Google Scholar
• Isenberg D. The use of B-cell depletion in the treatment of lupus. Lupus 2007; 10(Abstr Suppl)24–25
   Google Scholar
• Itoh K, et al. Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus. Arthritis Rheum 2006; 54(3)1020–1022
   PubMed Web of Science ®Google Scholar
• Berger JR, Koralnik IJ. Progressive multifocal leukoencephalopathy and natalizumab–unforeseen consequences. N Engl J Med 2005; 353(4)414–416
   PubMed Web of Science ®Google Scholar
• Furst D. Autologous stem cell transplant (SCT) for SLE: Progress and competition. Lupus 2007; 16(Abstr Suppl)70
   PubMed Web of Science ®Google Scholar
• Mosca M, Merrill J, Bombardieri S. Assessment of disease activity in systemic lupus erythematosus. Systemic lupus erythematosus, GC Tsokos, C Gordon, JS Smolen. Mosby/Elsevier, Philadelphia 2007; 19–23
   Google Scholar
• Ramsey-Goodman R, Gladman D. Disease development and outcome. Systemic lupus erythematosus, GC Tsokos, C Gordon, JS Smolen. Mosby/Elsevier, Philadelphia 2007; 24–31
   Google Scholar
• Petri M, Jones RJ, Brodsky RA. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus. Arthritis Rheum 2003; 48(1)166–173
   PubMed Web of Science ®Google Scholar
• Brodsky R, Jones R. Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: Advantages and disadvantages. Autoimmunity 2008, (in press)
   PubMed Web of Science ®Google Scholar
• Marmont AM. Lupus: Tinkering with haematopoietic stem cells. Lupus 2001; 10(11)769–774
   PubMed Web of Science ®Google Scholar